BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29:906-912. [PMID: 27905170 DOI: 10.1111/dote.12538] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Daiko H, Kato K. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer. Jpn J Clin Oncol 2020;50:847-51. [PMID: 32519741 DOI: 10.1093/jjco/hyaa082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Park SY, Hong MH, Kim HR, Lee CG, Cho JH, Cho BC, Kim DJ. The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma. J Thorac Dis 2020;12:6426-34. [PMID: 33282345 DOI: 10.21037/jtd-20-1088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:304-317. [PMID: 28556024 DOI: 10.3322/caac.21399] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 18.4] [Reference Citation Analysis]
5 Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119-130. [PMID: 28447000 DOI: 10.21037/acs.2017.03.14] [Cited by in Crossref: 186] [Cited by in F6Publishing: 152] [Article Influence: 37.2] [Reference Citation Analysis]
6 Hofstetter WL. Commentary: Maximizing response and outcomes in multimodality therapy for locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2019;157:1694-5. [PMID: 30642620 DOI: 10.1016/j.jtcvs.2018.12.018] [Reference Citation Analysis]
7 Kobayashi S, Taniguchi K, Tanaka F, Maeda S, Hirayama T, Tokunaga T, Takeshita H, Miura S, Kuroki T. Cricopharyngeal myotomy for cricopharyngeus muscle dysfunction after esophagectomy. Surg Case Rep 2020;6:205. [PMID: 32785797 DOI: 10.1186/s40792-020-00961-3] [Reference Citation Analysis]
8 Osorio J, Rodríguez-santiago J, Roig J, Pera M. Proyectos de estandarización del tratamiento del cáncer de la unión esofagogástrica: centralización, registros y formación. Cirugía Española 2019;97:470-6. [DOI: 10.1016/j.ciresp.2019.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yuan Y, Ma G, Hu X, Huang Q. Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study. Cancer Med 2020;9:4648-55. [PMID: 32391623 DOI: 10.1002/cam4.2997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang S, Zhou Z, Tian D, Huang S, Wang C, Gao Z, Ben X, Tang J, Xie L, Zhou H, Zhang D, Shi R, Deng C, Zhuang W, Ding Y, Qiao G. A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients. Ann Transl Med 2021;9:703. [PMID: 33987401 DOI: 10.21037/atm-21-1628] [Reference Citation Analysis]
11 Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD. The ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol 2018;117:1721-8. [PMID: 29949666 DOI: 10.1002/jso.25081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Tang H, Zheng H, Tan L, Shen Y, Wang H, Lin M, Wang Q. Neoadjuvant chemoradiotherapy followed by minimally invasive esophagectomy: is it a superior approach for locally advanced resectable esophageal squamous cell carcinoma? J Thorac Dis. 2018;10:963-972. [PMID: 29607169 DOI: 10.21037/jtd.2017.12.108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Soo RA, Stone EC, Cummings KM, Jett JR, Field JK, Groen HJ, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu Y, Higgins K, Senan S, Solomon B, Kim D, Johnson M, Yang JC, Sequist LV, Shaw AT, Ahn M, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR. Scientific Advances in Thoracic Oncology 2016. Journal of Thoracic Oncology 2017;12:1183-209. [DOI: 10.1016/j.jtho.2017.05.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
14 Kong M, Shen J, Zhou C, Yang H, Chen B, Zhu C, Wang G. Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery. Ann Transl Med 2020;8:1129. [PMID: 33240978 DOI: 10.21037/atm-20-4864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Jiang D, Wang H, Song Q, Wang H, Wang Q, Tan L, Hou Y. Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification. J Cancer 2020;11:1808-15. [PMID: 32194792 DOI: 10.7150/jca.34567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Rice TW, Blackstone EH. Staging of Cancer of the Esophagus and Esophagogastric Junction. In: Saba NF, El-rayes BF, editors. Esophageal Cancer. Cham: Springer International Publishing; 2020. pp. 127-37. [DOI: 10.1007/978-3-030-29832-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Mo R, Chen C, Pan L, Yu A, Wang D, Wang T. Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer? J Thorac Dis 2018;10:5192-8. [PMID: 30416766 DOI: 10.21037/jtd.2018.08.98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C; Worldwide Esophageal Cancer Collaboration Investigators. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016;29:913-9. [PMID: 27905171 DOI: 10.1111/dote.12540] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
19 Mo J, Chen D, Li C, Chen M. The Significance of Negative Lymph Nodes in Esophageal Cancer After Curative Resection: A Retrospective Cohort Study. Cancer Manag Res 2020;12:1269-79. [PMID: 32110101 DOI: 10.2147/CMAR.S232856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Oweira H, Schmidt J, Mehrabi A, Kulaksiz H, Schneider P, Schöb O, Giryes A, Abdel-Rahman O. Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer. Future Oncol 2018;14:65-75. [PMID: 29235888 DOI: 10.2217/fon-2017-0376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Chen D, Wang W, Chen Y, Hu J, Yang M, Mo J, Wen Z. Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery. Cancer Manag Res 2018;10:6109-20. [PMID: 30538559 DOI: 10.2147/CMAR.S186194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
22 Hofstetter WL. Open versus hybrid minimally invasive esophagectomy: Join the crowd, but do not throw away your abdominal retractors just yet. The Journal of Thoracic and Cardiovascular Surgery 2019;158:1475-8. [DOI: 10.1016/j.jtcvs.2019.05.090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sisic L, Blank S, Nienhüser H, Dorr S, Haag GM, Jäger D, Bruckner T, Müller-Stich BP, Ott K, Büchler MW, Ulrich A, Schmidt T. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment. Eur J Surg Oncol 2018;44:1646-56. [PMID: 30082176 DOI: 10.1016/j.ejso.2018.06.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Rice TW, Lu M, Ishwaran H, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators. Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction. J Thorac Oncol. 2019;14:2164-2175. [PMID: 31442498 DOI: 10.1016/j.jtho.2019.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yap W, Chang Y, Hsieh C, Chao Y, Chen C, Shih M, Hung T. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging 2018;45:689-98. [DOI: 10.1007/s00259-017-3901-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 D'Journo XB. Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 2018;10:S2671-81. [PMID: 30345104 DOI: 10.21037/jtd.2018.03.182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
27 Kröll D, Noser L, Erdem S, Storni F, Arnold D, Dislich B, Zlobec I, Candinas D, Seiler CA, Langer R. Application of the 8th edition of the AJCC yTNM staging system shows improved prognostication in a single center cohort of esophageal carcinomas. Surgical Oncology 2018;27:100-5. [DOI: 10.1016/j.suronc.2017.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Miyata H, Sugimura K, Yamasaki M, Makino T, Tanaka K, Morii E, Omori T, Yamamoto K, Yanagimoto Y, Yano M, Nakatsuka S, Mori M, Doki Y. Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal Cancer. Ann Surg Oncol 2019;26:200-8. [DOI: 10.1245/s10434-018-6946-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
29 Zhong J, Wang K, Fang S, Fu J. Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy. Eur J Surg Oncol 2021:S0748-7983(21)00454-6. [PMID: 34023168 DOI: 10.1016/j.ejso.2021.04.026] [Reference Citation Analysis]
30 Merritt RE, Abdel-Rasoul M, Souza DM, Kneuertz PJ. Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma. J Surg Oncol 2021;123:881-90. [PMID: 33333590 DOI: 10.1002/jso.26349] [Reference Citation Analysis]
31 Hu K, Kang N, Liu Y, Guo D, Jing W, Lu J, Tan T, Lv C, Deng Y, Long J, Wang R, Yu J. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. Cancer Sci 2019;110:717-25. [PMID: 30467921 DOI: 10.1111/cas.13891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
33 Raja S, Rice TW, Murthy SC, Ahmad U, Semple ME, Blackstone EH, Ishwaran H; Worldwide Esophageal Cancer Collaboration Investigators. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma. Ann Surg 2021;274:e320-7. [PMID: 31850981 DOI: 10.1097/SLA.0000000000003598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
34 Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer. J Thorac Oncol. 2017;12:36-42. [PMID: 27810391 DOI: 10.1016/j.jtho.2016.10.016] [Cited by in Crossref: 160] [Cited by in F6Publishing: 188] [Article Influence: 26.7] [Reference Citation Analysis]
35 Hsu PK, Chen HS, Liu CC, Wu SC. Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2018;105:1516-22. [PMID: 29409986 DOI: 10.1016/j.athoracsur.2017.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
36 Depypere L, De Hertogh G, Moons J, Provoost AL, Lerut T, Sagaert X, Coosemans W, Van Veer H, Nafteux P. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. Ann Thorac Surg 2020:S0003-4975(20)32144-5. [PMID: 33352178 DOI: 10.1016/j.athoracsur.2020.09.074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Tang H, Tan L, Wang H, Shen Y, Yin J. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved. J Gastrointest Surg 2020;24:1469-76. [DOI: 10.1007/s11605-019-04317-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Merritt RE, Kneuertz PJ, Abdel-Rasoul M, D'Souza DM, Perry KA. Comparative analysis of long-term oncologic outcomes for minimally invasive and open Ivor Lewis esophagectomy after neoadjuvant chemoradiation: a propensity score matched observational study. J Cardiothorac Surg 2021;16:347. [PMID: 34872562 DOI: 10.1186/s13019-021-01728-z] [Reference Citation Analysis]
39 Zopfs D, Große Hokamp N, Reimer R, Bratke G, Maintz D, Bruns C, Mallmann C, Persigehl T, Haneder S, Lennartz S. Value of spectral detector CT for pretherapeutic, locoregional assessment of esophageal cancer. Eur J Radiol 2021;134:109423. [PMID: 33302024 DOI: 10.1016/j.ejrad.2020.109423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Li H, Fang W, Yu Z, Mao Y, Chen L, He J, Rong T, Chen C, Chen H, Chen K, Du M, Han Y, Hu J, Fu J, Hou X, Gong T, Li Y, Liu J, Liu S, Tan L, Tian H, Wang Q, Xiang J, Xu M, Ye X, You B, Zhang R, Zhao Y; Society of Esophageal Tumor, Chinese Anti-Cancer Association. Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition). J Thorac Dis 2018;10:2481-9. [PMID: 29850156 DOI: 10.21037/jtd.2018.03.175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
41 Depypere LP, Vervloet G, Lerut T, Moons J, De Hertogh G, Sagaert X, Coosemans W, Van Veer H, Nafteux PR. ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up? J Thorac Dis 2018;10:2771-8. [PMID: 29997939 DOI: 10.21037/jtd.2018.04.136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhang YH, Herlin G, Rouvelas I, Nilsson M, Lundell L, Brismar TB. Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response. Dis Esophagus 2019;32:doy096. [PMID: 30295752 DOI: 10.1093/dote/doy096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
43 Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma. Surg Oncol 2020;35:491-7. [PMID: 33130441 DOI: 10.1016/j.suronc.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Wang H, Chen Y, Pi G, Zhu Y, Yang S, Mei H, Lin Z, Zhang T. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification. Oncol Lett. 2020;19:4122-4132. [PMID: 32382351 DOI: 10.3892/ol.2020.11480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]